Outlook Therapeutics Inc (OTLK): Next-Year EPS Estimate 53.05%
As of 2026-06-11, Outlook Therapeutics Inc (OTLK) has a next-year EPS growth estimate of 53.05%.
On 2026-06-11, analyst consensus for OTLK's next-year EPS growth shifted from 48.28% to 53.05% — a positive change of 4.77 percentage points. Current-year growth is projected at 72.65%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 53.05%
- EPS growth this year
- 72.65%
- EPS next quarter (est)
- -$0.10
- Last price
- $1.10
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 53.05% | 72.65% | -$0.10 | $1.10 |
| 2026-06-10 | 48.28% | 71.40% | -$0.11 | $0.89 |
| 2026-06-09 | 48.28% | 71.40% | -$0.11 | $0.70 |
| 2026-06-08 | 48.28% | 71.40% | -$0.11 | $0.72 |
| 2026-06-07 | 48.28% | 71.40% | -$0.11 | $0.78 |
| 2026-06-04 | 48.28% | 71.40% | -$0.11 | $0.79 |
| 2026-06-03 | 48.28% | 71.40% | -$0.11 | $0.81 |
| 2026-06-02 | 48.28% | 71.40% | -$0.11 | $0.81 |
| 2026-06-01 | 48.28% | 71.40% | -$0.11 | $0.84 |
| 2026-05-31 | 48.28% | 71.40% | -$0.11 | $0.73 |
| 2026-05-28 | 48.28% | 71.40% | -$0.11 | $0.74 |
| 2026-05-27 | 48.28% | 71.40% | -$0.11 | $0.59 |
| 2026-05-26 | 46.12% | 72.37% | -$0.11 | $0.40 |
| 2026-05-25 | 46.12% | 72.37% | -$0.11 | $0.31 |
| 2026-05-24 | 46.12% | 72.37% | -$0.11 | $0.31 |
| 2026-05-21 | 46.12% | 72.37% | -$0.11 | $0.33 |
| 2026-05-20 | 46.12% | 72.37% | -$0.11 | $0.27 |
| 2026-05-19 | 46.12% | 72.37% | -$0.11 | $0.23 |
| 2026-05-18 | 46.12% | 72.37% | -$0.11 | $0.23 |
| 2026-05-17 | 47.35% | 71.73% | -$0.11 | $0.23 |
| 2026-05-14 | 47.35% | 71.73% | -$0.12 | $0.23 |
| 2026-05-13 | 47.35% | 71.73% | -$0.12 | $0.24 |
| 2026-05-12 | 47.35% | 71.73% | -$0.12 | $0.24 |
| 2026-05-11 | 47.35% | 71.73% | -$0.12 | $0.25 |
| 2026-05-10 | 47.35% | 71.73% | -$0.12 | $0.22 |
| 2026-05-07 | 47.35% | 71.73% | -$0.12 | $0.22 |
| 2026-05-06 | 47.35% | 71.73% | -$0.12 | $0.23 |
| 2026-05-05 | 47.35% | 71.73% | -$0.12 | $0.24 |
| 2026-05-04 | 47.35% | 71.73% | -$0.12 | $0.26 |
| 2026-05-03 | 47.35% | 71.73% | -$0.12 | $0.26 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Outlook Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Outlook Therapeutics Inc (OTLK) has a next-year EPS growth estimate of 53.05%, based on analyst consensus.
When was the latest EPS estimate revision for OTLK?▾
The most recent revision occurred on 2026-06-11, when analysts adjusted the next-year EPS growth estimate from 48.28% to 53.05%.
What sector and industry does Outlook Therapeutics Inc belong to?▾
Outlook Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. OTLK appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Outlook Therapeutics Inc (OTLK) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports